confirmed the importance of MR blockers to prevent cardiovascular complications and cerebrovascular accidents even in patients with normal values of Aldo (16, 17) and several studies are evaluating a possible terapeuthic role of MR blockers to treat obesity and metabolic disorders (18). Here, NR3C2 is linked to Other metabolic disease.